Intensive Update in Pain Management 2019

Topics/Speaker:
The Fundamentals

Spinal Cord Stimulation – Mechanism of Action – Ricardo Vallejo, MD, PhD

Evaluation and Treatment of Neck and Arm Pain – Following Cervical Fusion – Thomas Mroz, MD

Sacroiliac Joint RFA: Indications, Better Technique, Better Outcomes? – David “DJ” Kennedy, MD

Cervical Spine Surgery: Watchful Waiting vs. Decompression – Thomas Mroz, MD

New Algorithm for Treatment of Chronic Abdominal Pain – Leo Kapural, MD, PhD

Core Stability – David “DJ” Kennedy, MD

Panel Discussion/Question and Answer

Regulatory, Billing and Ethical Challenges in Pain Practice

Neuromodulation – Will Overuse Kill the Technology? – Timothy R. Deer, MD

Effective Payer Negotiations – Damean Freas, DO

CPT and RUC: How is a Code Created and Get Value? – Richard W. Rosenquist, MD

Effective Billing for Neuromodulation Procedures – Robert Bolash, MD

Medical and Ethical Concerns in Billing – Damean Freas, DO

Emerging Pharmacological and Interventional Treatment

Basivertebral Nerve Ablation for Chronic Vertebrogenic Back Pain – David “DJ” Kennedy, MD

The ReActiv8 Trial – Christopher J. Gilligan, MD

CGRP Antagonists – MaryAnn Mays, MD

Nerve Growth Factor – Mark S. Wallace, MD

Nav1.7 as a Pharmacogenomic Target for Pain – Robert Bolash, MD

Neuromodulation: Effective Utilization of Targets, Techniques, and Devices

Neurostimulation: From Inception to the Future – Nagy Mekhail, MD, PhD

Tonic Stimulation – Ricardo Vallejo, MD, PhD

Burst Stimulation – Timothy R. Deer, MD

High Frequency Stimulation – Leo Kapural, MD, PhD

Feedback Modified Stimulation – Nagy Mekhail, MD, PhD

Intrathecal Drug Delivery – Robert Bolash, MD

Dorsal Root Ganglion Stimulation – Timothy R. Deer, MD

Neuromodulation – Changing Paradigms and Devices: How Do I Choose the Best One for My Patient?

Matching the Diagnosis and the Technique/Device for the Best Patient Outcome – A Case Discussion with the Experts – Nagy Mekhail, MD, PhD

Panel Discussion/Question and Answer

The Opioid Crisis

Buprenorphine: A Viable Alternative? – Robert Bolash, MD

Pharmacogenomics: Fad or the Future? – Jennifer Hockings, PharmD, PhD

Evolving Role of Pain Physicians in Identifying and Treating Opioid Use Disorder – Richard W. Rosenquist, MD

Opioid Stewardship at the Enterprise Level – Christopher J. Gilligan, MD

FDA Approved Direct to Consumer Pharmacogenomic Testing: How Do I Respond? – Jennifer Hockings, PharmD, PhD

Ketamine for Pain Medicine

Ketamine for Chronic Pain – Samuel Samuel, MD

Ketamine for Acute Pain – Sree Kolli, MD

Ketamine: Miracle Drug or Latest Fad? – Teresa Dews, MD

Contraindications to Ketamine Treatment – Samuel Samuel, MD

Non-Pain Related Applications of Ketamine – Christopher J. Gilligan, MD

Ketamine for CRPS – Jijun Xu, MD, PhD

Panel Discussion/Question and Answer

Medical Marijuana

Role of Cannabinoids in Chronic Pain Treatment – Mark S. Wallace, MD

Adverse Effects of Cannabinoids – Scott Petersen, PA-C

Oils, Edibles, Smoking, and Vaping: How Do You Decide? – Mark S. Wallace, MD

Headaches

Evaluating the Headache Patient: When is Imaging Indicated? – Imanuel R. Lerman, MD

Rational Approach to Pharmacological Migraine Treatment – MaryAnn Mays, MD

Interventional Approaches to Headache Management – Samuel Samuel, MD

Adverse Effects of Pharmacological Treatments – MaryAnn Mays, MD

Panel Discussion/Question and Answe